Showing results (1441-1450 of 1,731) with videos related to

Sort By:
Pageof 174
Journal of Shoulder and Elbow Surgery|June 5, 2023
Superior migration of the humeral head does not significantly affect outcomes at an average of 11 years after total shoulder arthroplastyAkiro H Duey, James D Dieterich, Akshar V Patel, et al.
Gene Expression Patterns : GEP|July 11, 2006
Detection of novel skeletogenesis target genes by comprehensive analysis of a Runx2(-/-) mouse modelJ Hecht, V Seitz, M Urban, et al.
Nature Communications|November 14, 2017
A post-transcriptional program coordinated by CSDE1 prevents intrinsic neural differentiation of human embryonic stem cellsHyun Ju Lee, Deniz Bartsch, Cally Xiao, et al.
Molecular Systems Biology|September 17, 2017
A proteomic atlas of insulin signalling reveals tissue-specific mechanisms of longevity assuranceLuke S Tain, Robert Sehlke, Chirag Jain, et al.
American Journal of Medical Genetics. Part A|November 7, 2015
Microdeletion del(22)(q12.1) excluding the MN1 gene in a patient with craniofacial anomaliesCaroline Bosson, Françoise Devillard, Véronique Satre, et al.
Journal of Molecular Biology|April 21, 2004
Caldendrin but not calmodulin binds to light chain 3 of MAP1A/B: an association with the microtubule cytoskeleton highlighting exclusive binding partners for neuronal Ca(2+)-sensor proteinsConstanze I Seidenbecher, Marco Landwehr, Karl-Heinz Smalla, et al.
European Journal of Neurology|March 4, 2021
First symptom guides diagnosis and prognosis in neurodegenerative diseases-a retrospective study of autopsy proven casesJonathan Vöglein, Irena Kostova, Thomas Arzberger, et al.
Annals of Clinical and Translational Neurology|August 29, 2020
Global multisensory reorganization after vestibular brain stem strokeJulian Conrad, Maximilian Habs, Rainer Boegle, et al.
Scientific Reports|July 25, 2022
Evidence for correlations between BMI-associated SNPs and circRNAsLuisa Sophie Rajcsanyi, Inga Diebels, Lydia Pastoors, et al.
Alimentary Pharmacology & Therapeutics|July 11, 2017
Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patientsM P Curry, E B Tapper, B Bacon, et al.
Pageof 174